Viewing Study NCT02674750


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-02-01 @ 6:59 PM
Study NCT ID: NCT02674750
Status: COMPLETED
Last Update Posted: 2022-04-27
First Post: 2016-01-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations
Sponsor: Curis, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DLBCL View
None MYC View